Sarah Sherman
About Sarah Sherman
Sarah Sherman is an Associate Director at Kite Pharma, with extensive experience in clinical trial management. She has held various roles in the pharmaceutical industry, including positions at Dendreon, Gilead Sciences, and Immunex Corporation.
Current Role at Kite Pharma
Sarah Sherman serves as the Associate Director at Kite Pharma, a role she has held since 2021. Based in Seattle, Washington, she has contributed to the company's clinical operations for three years. In this position, she oversees various aspects of clinical trials and ensures compliance with regulatory standards, enhancing the efficiency of clinical programs.
Previous Experience at Kite Pharma
Before her current role, Sarah Sherman worked at Kite Pharma as a Senior Clinical Trials Manager from 2018 to 2020. During this two-year period, she managed clinical trial operations and collaborated with cross-functional teams to support the development of innovative therapies. Additionally, she served as a Clinical Program Manager at Kite Pharma from 2020 to 2021, further solidifying her expertise in clinical trial management.
Experience at Gilead Sciences
Sarah Sherman held multiple positions at Gilead Sciences, where she worked as a Clinical Trials Manager from 2014 to 2016 and later as a Senior Clinical Trials Manager from 2016 to 2018. Her work in Seattle, Washington, involved managing clinical trial activities, ensuring adherence to protocols, and facilitating communication among stakeholders to drive project success.
Background in Clinical Research
Sarah Sherman began her career in clinical research at Immunex Corporation, where she worked as a Clinical Operations Coordinator from 2001 to 2003. She then joined Dendreon, where she held various roles, including Senior Clinical Research Associate II from 2005 to 2013 and Clinical Trial Manager from 2013 to 2014. This extensive background provided her with a solid foundation in clinical operations and trial management.
Education and Qualifications
Sarah Sherman earned a Bachelor of Science (BS) degree in Communication and Media Studies from Hampshire College, where she studied from 2002 to 2006. This educational background has contributed to her effective communication skills and understanding of media in the context of clinical research and trial management.